Four New Verigene Outcomes Studies to be Presented at IDWeek 2015

Four new outcomes studies associated with implementation of Verigene® Gram-Positive (BC-GP) and Gram-Negative (BC-GN) Blood Culture Tests will be presented during IDWeek 2015 in San Diego this week.

These studies focus on the clinical impact that BC-GP and BC-GN paired with pharmacy and/or antimicrobial stewardship team (AST) intervention can have on optimization of antimicrobial therapy and patient outcomes:

Saturday, October 10th

  • Poster 1486. Impact of Rapid Molecular Testing of Gram-Positive Blood Culture Isolates Using Verigene Gram-Positive Blood Culture (BC-GP) on Antimicrobial Stewardship and Clinical Outcomes within a Community Health System.
  • Institution: NorthShore University Health System, Evanston
  • Abstract
  • Poster 1487. Antimicrobial Stewardship and the Use of Verigene Gram-Positive and Gram-Negative Rapid Identification System.
    • Institution: University of Kentucky Healthcare System
    • Abstract
  • Poster 1491. Improved Clinical Outcomes after Implementation of Molecular Detection of Blood Culture Contaminants.
    • Institution: Banner-University Medical Center
    • Abstract
  • Poster 1492. Experience with Rapid Diagnostic Technology and Antimicrobial Stewardship for Patients with Gram-Positive Bloodstream Infections.
    • Institution: Cleveland Clinic
    • Abstract

    Click here to contact your local Clinical Sales Representative